Digital Inhaler Use in Obstructive Lung Disease Care
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Cedars-Sinai Medical Center
- Study ID
- NCT07214337
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Chronic Obstructive Airway Disease
- Chronic Obstructive Airways Disease Exacerbated
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Digital Inhaler Attachment — DEVICEThis intervention is the attachment of a digital device to provide patient with coaching for optimal inhaler use and technique, as well as monitoring of patient use of inhaler to patient and health care team. Patient will continue to use inhalers prescribed as per usual care for management of COPD.
Study Details
This is a pilot study to evaluate the role digital inhaler technology on patients with obstructive lung disease in preventing admissions and exacerbation, as well as improving symptom control. The primary objective is to evaluate feasibility of study protocol, patient recruitment, and patient retention with goal recruitment of 20 participants, 60% recruitment success, and 60% retention rate for 6 months duration. The secondary objectives are the evaluation of patient admission rate, exacerbation rates, and symptoms control with use of digital inhaler technology The subject population will be patients with physician diagnosed obstructive lung disease.
Key Dates
- Start date
- Nov 1, 2025
- Status verified
- Oct 2025
- Primary completion
- Jan 31, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Other: Digital Inhaler Attachment for Regular CareThis group of patients will be provided interactive device that provides inhaler coaching for to use for 6 month duration.
Primary Outcome Measure
Participant Recruitment Percentage [ Time Frame: 6 months ]
Central Contacts
- Vinita Kusupati, MD14016512622
- Sara Ghandehari, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | Vinita Kusupati, MD (SUB_INVESTIGATOR) Sara Ghandehari, MD (PRINCIPAL_INVESTIGATOR) |